Attività
Vendite per attività
EUR in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Nanotechnology and Drug Particle Engineering
100,0
%
| 3 | 100,0 % | 3 | 100,0 % | -26,41% |
Vendite per regione
EUR in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Europe
57,0
%
| 2 | 56,2 % | 1 | 57,0 % | -25,37% |
United States
43,0
%
| 2 | 43,8 % | 1 | 43,0 % | -27,73% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Edward Hæggström
CEO | Chief Executive Officer | 55 | 01/01/15 |
Albert Häggström
DFI | Director of Finance/CFO | 53 | 01/01/15 |
Investor Relations Contact | - | 01/05/19 | |
Antonio da Silva
PRN | Corporate Officer/Principal | 50 | 01/01/19 |
Peter Hänninen
LAW | General Counsel | 36 | 01/09/20 |
David Rowe
PRN | Corporate Officer/Principal | 57 | 01/01/19 |
Christian Jones
PRN | Corporate Officer/Principal | 44 | 01/01/18 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Chairman | 68 | 02/04/19 | |
Mads Laustsen
BRD | Director/Board Member | 67 | 01/01/19 |
Albert Häggström
DFI | Director of Finance/CFO | 53 | 01/01/15 |
Jeanne A. Thoma
BRD | Director/Board Member | 64 | 01/10/21 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 85 445 164 | 59 636 291 ( 69,79 %) | 0 | 69,79 % |
Coordinate società
Settore
Vendite per regione
Variaz. 1 gen. | Capi. | |
---|---|---|
+29,77% | 49,46 Mrd | |
+1,00% | 42,58 Mrd | |
+49,79% | 42,49 Mrd | |
-5,26% | 29,09 Mrd | |
+13,68% | 26,61 Mrd | |
-22,99% | 18,64 Mrd | |
+8,22% | 13,16 Mrd | |
+32,41% | 12,55 Mrd | |
+24,01% | 12,1 Mrd |